Sunanda Ray, Terry Samuel, Jeremy Hawker, Steve Smith Despite guidance from the Department of Health and the Renal Association that dialysis patients should be offered prophylaxis against hepatitis B by immunisation, surveys have shown that 95% of renal units in 1994 and 49% in 1995 were not routinely offering immunisation to any patient groups with chronic renal failure. [1] [2] [3] [4] We aimed to determine whether provision of hepatitis B immunisation had improved after publication of the 1996 Department of Health guidelines and to identify barriers to implementation of existing guidelines.
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Participants, methods, and results
We sent a postal questionnaire, piloted in five renal units, to the clinical directors of all 87 main UK renal units and satellites. The questionnaire (available on bmj.com) covered hepatitis B immunisation in patients with chronic renal failure, including those receiving renal replacement therapy; the number of cases of acute hepatitis B infection between 1997 and 1999; and reasons why patients might not be vaccinated.
Seventy eight (90%) units responded. Units in two teaching and four district general hospitals plus three satellites did not respond, despite reminders. Twelve units (15%) reported at least one incident of hepatitis B seroconversion in a dialysis patient. Twenty three units (29%) did not immunise any patient groups. A further six units offered immunisation only to patients planning treatment in hepatitis B endemic areas outside the United Kingdom.
Completeness of hepatitis B immunisation in dialysis patients was not known in 27 units (35%), less than 25% in 17 units (22%), 25-75% in 13 units (17%), and over 75% in 20 units (26%). Of the 55 units that provided immunisation, 70% gave the recommended higher dose of 40 g whereas 30% gave the previously recommended dose of 20 g. Most (72%) used the earlier schedule of doses at 0, 1, and 6 months instead of the recommended accelerated schedule of 0, 1, 2, and 12 months. The table lists the reasons why patients are not routinely immunised.
Thirty six units (46%) followed the Renal Association's recommendations on hepatitis B immunisation of patients with chronic renal failure; 42 did not. Fourteen units had developed their own policies. Eleven units (14%) mentioned alternative guidance on immunisation, including the Department of Health's "green book" on infectious diseases, 1 the revised Rosenheim report (the draft Department of Health's policy in development), 4 and the British National Formulary. One unit feared that staff might become less careful with universal precautions if all patients were immunised. Two units thought that the heavy workload produced little benefit. One unit abandoned an immunisation programme it had started after a seroconver- We thank all UK renal units who completed the study questionnaire and the staff at the Communicable Disease Surveillance Centre, Birmingham Heartlands Hospital. Contributors: SS and JH had the original idea for this study. SR designed the study questionnaire and played a key part in data collection, data documentation, and analysis. TS participated in the study design, data collection, and analysis. SR and TS jointly wrote the paper. SS and JH edited the paper. SS will act as guarantor for the paper.
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Workplace bullying in junior doctors: questionnaire survey
Lyn Quine
In the United Kingdom a growing literature has identified workplace bullying as a major occupational stressor among health professionals. A study carried out in an NHS community trust found that 1 in 3 staff reported being bullied in the previous year, 1 while a report by the King's Fund, an independent health think tank, found that bullying, racial harassment, and discrimination were daily experiences for black and Asian doctors. In the United States several studies have reported that medical students suffer high levels of mistreatment or bullying during training, which increase with progression through medical school, spilling over into the early training years.
2-4 We report here findings from a study of workplace bullying among junior doctors in the United Kingdom.
Participants, methods, and results
An anonymous questionnaire was sent out with BMA News Review to 1000 doctors with job grades from house officer to senior registrar, randomly selected from the BMA members' mailing list. The questionnaire collected information about the participant's age, sex, job grade, and ethnic group. Participants were presented with a definition of bullying and asked to indicate whether they had been subjected to it in the past 12 months and whether they had witnessed others being bullied. They also completed a bullying scale which asked whether they had experienced 21 bullying behaviours from peers, senior staff, or managers in the past 12 months.
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The response rate was 62%: 594 competed questionnaires were returned and 48 were returned undelivered by the post office. Not all questions were answered by all participants. Fifty four per cent (321) of the participants were house officers or senior house officers, 39% (230) registrars, 3% (18) senior registrars, and 3% (20) other junior grades. Half were men (294 v 296) and 70% (413 v 174) were white. Overall, 220 of the 594 junior doctors (37%) identified themselves as having been bullied in the past year, though 486 (84%) had in fact experienced one or more of the bullying behaviours described on the bullying scale; 407 (69%) had witnessed the bullying of others. Black and Asian doctors were more likely to report being bullied than white doctors (78 (45%) v 139 (34%); 2 = 6.3, df = 1, n = 585, P = 0.01; relative risk 1.59 (95% confidence interval 1.11 to 2.28)) and women were more likely to report being bullied than men (43% (126) v 32% (92); 2 = 7.7, df = 1, n = 588, P = 0.005; relative risk 1.61 (1.14 to 2.26); see table). Reports of bullying did not vary by job grade or age.
Comment
In this study 37% of junior doctors reported being bullied in the previous year and 84% had experienced at least one bullying behaviour. Black and Asian doctors were more likely to be bullied than other doctors. This should be a cause for concern, particularly since several recent studies show a pattern of discrimination at all levels in the medical profession from application to medical school to examination success, job application, and the allocation of distinction awards to consultants.
5 Women were more likely than men to be bullied, and this finding is consistent with a study of university employees by Bjorkvist et al.
